• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[衣原体性尿道炎的治疗——氧氟沙星临床疗效研究]

[Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin].

作者信息

Asano H, Hibi H, Ohshima S, Kinukawa T, Matuura O, Takeuchi N, Hattori R, Hasegawa S, Fujita T, Matsui M

机构信息

Department of Urology, Aichi Saisikai Hospital.

出版信息

Hinyokika Kiyo. 1989 Jan;35(1):191-7.

PMID:2729017
Abstract

Clinical effects of ofloxacin (OFLX) in the treatment of the patients with chlamydial urethritis was studied. OFLX was administered at a dose of 200 mg, three times daily (600 mg) for 14 days. In all of the 26 patients with chlamydial urethritis, C. trachomatis was eliminated in 7 to 14 days after the start of administration. The subjective clinical symptoms such as pain on urination and abnormal urethral feeling was disappeared in all cases within 7 days after the administration. The objective clinical symptoms, urethral discharge, polymorphonuclear leukocyte (PMNL) in urethral discharge and PMNL in first urine were improved in 94, 68, 91% respectively on 14 days after the administration. Overall clinical efficacy rate of OFLX on 7 days, 14 days and 21 days after the administration in this study was 63, 82, 91% respectively. Whereas subjective symptoms of side effects were noted in 2 patients (7.6%), any additional medical care was needed in none of them. Because of the marked improvement of clinical symptoms and the safety administration, OFLX could be the first regimen to be chosen for the treatment of the patients with chlamydial urethritis.

摘要

研究了氧氟沙星(OFLX)治疗衣原体尿道炎患者的临床效果。氧氟沙星给药剂量为200毫克,每日三次(600毫克),共14天。在所有26例衣原体尿道炎患者中,给药开始后7至14天沙眼衣原体被清除。所有病例在给药后7天内排尿疼痛和尿道异常感觉等主观临床症状均消失。给药14天后,客观临床症状、尿道分泌物、尿道分泌物中的多形核白细胞(PMNL)和首次尿液中的PMNL分别改善了94%、68%、91%。本研究中氧氟沙星给药后7天、14天和21天的总体临床有效率分别为63%、82%、91%。2例患者(7.6%)出现了副作用的主观症状,但均无需额外医疗护理。由于临床症状明显改善且给药安全,氧氟沙星可作为治疗衣原体尿道炎患者的首选方案。

相似文献

1
[Treatment of chlamydial urethritis--studies on clinical effects of ofloxacin].[衣原体性尿道炎的治疗——氧氟沙星临床疗效研究]
Hinyokika Kiyo. 1989 Jan;35(1):191-7.
2
[Treatment of nongonococcal urethritis--studies on clinical effects of ofloxacin].[非淋菌性尿道炎的治疗——氧氟沙星临床疗效研究]
Hinyokika Kiyo. 1986 Feb;32(2):303-9.
3
[Ofloxacin for the treatment of chlamydial urethritis].氧氟沙星治疗衣原体尿道炎
Hinyokika Kiyo. 1988 Sep;34(9):1687-90.
4
[Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis].氧氟沙星治疗沙眼衣原体所致男性尿道炎的临床疗效研究
Hinyokika Kiyo. 1988 Mar;34(3):569-73.
5
[Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].氧氟沙星治疗男性性传播尿道炎和宫颈炎的疗效
Jpn J Antibiot. 1988 Oct;41(10):1445-79.
6
Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia.氧氟沙星治疗非淋菌性尿道炎。一项在亚洲开展的多中心研究。
Arzneimittelforschung. 1990 Feb;40(2 Pt 1):190-2.
7
[Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males].
Pathol Biol (Paris). 1986 May;34(5):502-4.
8
[Clinical feature of male non-gonorrhoea urethritis and minocycline treatment of Chlamydia or Ureaplasma-infected urethritis].[男性非淋菌性尿道炎的临床特征及米诺环素治疗衣原体或脲原体感染性尿道炎]
Hinyokika Kiyo. 1987 Oct;33(10):1724-7.
9
[Clinical studies of Chlamydia trachomatis in male urethritis].
Hinyokika Kiyo. 1989 Jan;35(1):77-81.
10
Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.氧氟沙星治疗非淋菌性性传播疾病的疗效与安全性。 需注意,原英文文本中“of ofloxacin”多了一个“of”,正确表述应该是“Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.”
Am J Med. 1989 Dec 29;87(6C):75S-77S.

引用本文的文献

1
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.氧氟沙星。对其抗菌活性、药理学及治疗用途的重新评估。
Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.